Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial

Patrick J. Loehrer, Michael Chen, KyungMann Kim, Seena C. Aisner, Lawrence H. Einhorn, Robert Livingston, David Johnson

Research output: Contribution to journalArticlepeer-review

188 Scopus citations

Fingerprint

Dive into the research topics of 'Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial'. Together they form a unique fingerprint.

Medicine & Life Sciences